ArticleAngewandte Chemie (International ed. in English)2026
Coupling Exponential Rolling Circle Amplification to Lateral Flow Devices for Point-of-Care Detection of Viral RNA.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Sensitive detection of viral RNA in biological samples remains challenging because of low viral loads, complex matrices, and RNA secondary structures. Here, we present a heat-free, reverse-transcription-free lateral flow platform that converts structured viral RNA into visual signals through RNase I-mediated primer generation, exponential rolling circle amplification (E-RCA), and toehold-mediated strand displacement (TMSD). The newly developed E-RCA circuit uses a single additional primer, P2, which is extended on primary RCA products and then processed by Φ29 DNA polymerase to generate a feedback primer, enabling rapid exponential amplification from a circular DNA template. RCA products and P2-extended products subsequently trigger a newly designed TMSD module to release bridging DNA strands that generate visible lateral flow signals. Using SARS-CoV-2 as a model, the assay achieved detection limits down to 500 aM, sample-to-result times of approximately 45 min, and 95%-100% accuracy across four viral RNA regions in clinical saliva samples, providing a platform for rapid point-of-care RNA diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.